Early response monitoring of neoadjuvant chemotherapy using [18F]FDG PET can predict the clinical outcome of extremity osteosarcoma

Early response monitoring of neoadjuvant chemotherapy using [18F]FDG PET can predict the clinical outcome of extremity osteosarcoma

Abstract Background To propose a personalized therapeutic approach in osteosarcoma treatment, we assessed whether sequential [18F]FDG PET/CT (PET/CT) could predict the outcome of patients with osteosarcoma of the extremities after one cycle and two cycles of neoadjuvant chemotherapy. Methods A total...

Full description

Bibliographic Details
Main Authors: Inki Lee, Byung Hyun Byun, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Jae-Soo Koh, Won Seok Song, Wan Hyeong Cho, Chang-Bae Kong, Sang Moo Lim
Format: Article
Language:English
Published: SpringerOpen 2020-01-01
Series:EJNMMI Research
Subjects:
Osteosarcoma
[18F]Fluorodeoxyglucose
Positron emission tomography
Standardized uptake value
Event-free survival
Online Access:https://doi.org/10.1186/s13550-019-0588-4

Internet

https://doi.org/10.1186/s13550-019-0588-4

Similar Items